» Articles » PMID: 12552492

Beneficial Effects of Weight Loss in Overweight Patients with Chronic Proteinuric Nephropathies

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 2003 Jan 29
PMID 12552492
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Proteinuria is a recognized complication of obesity, but no study has investigated the effect of weight loss in overweight patients with chronic proteinuric nephropathies of different causes.

Methods: We randomly assigned (in a 2:1 ratio) 30 overweight patients (body mass index [BMI] > 27 kg/m(2)) with diabetic and nondiabetic proteinuric nephropathies to either follow a low-calorie normoproteinic diet or maintain their usual dietary intake for 5 months. The primary outcome was change in urinary protein excretion. Secondary outcomes were changes in renal function (serum creatinine level and Cockcroft-Gault creatinine clearance) and lipid profile.

Results: Patients in the diet group showed a significant decrease in body weight and BMI, whereas patients in the control group showed a significant increase in body weight and BMI (between-group comparison, P < 0.05). Mean weight loss in the diet group was 4.1% +/- 3%, and 14 of 20 patients in this group lost more than 3%. Proteinuria decreased by 31.2% +/- 37% in the diet group (from protein of 2.8 +/- 1.4 to 1.9 +/- 1.4 g/24 h; P < 0.005), whereas it tended to increase in the control group (between-group comparison, P < 0.05). Changes in renal function did not differ significantly between groups, although renal function remained stable in the diet group and showed significant worsening in the control group. Serum triglyceride levels remained stable in the diet group and tended to increase in the control group (between-group comparison, P < 0.05).

Conclusion: Moderate weight loss in overweight patients with chronic proteinuric nephropathies induces a significant decrease in proteinuria. Am J Kidney Dis 41:319-327.

Citing Articles

Obesity-Related Chronic Kidney Disease: From Diagnosis to Treatment.

Avgoustou E, Tzivaki I, Diamantopoulou G, Zachariadou T, Avramidou D, Dalopoulos V Diagnostics (Basel). 2025; 15(2).

PMID: 39857056 PMC: 11763674. DOI: 10.3390/diagnostics15020169.


Kidney consequences of obesity.

Nehus E, Mitsnefes M Pediatr Nephrol. 2024; .

PMID: 39680134 DOI: 10.1007/s00467-024-06623-y.


Approaches to patients with obesity and CKD: focus on nutrition and surgery.

Bellizzi V, Annunziata G, Albanese A, DAlessandro C, Garofalo C, Foletto M Clin Kidney J. 2024; 17(Suppl 2):51-64.

PMID: 39583144 PMC: 11581770. DOI: 10.1093/ckj/sfae291.


Exploring Adiposity and Chronic Kidney Disease: Clinical Implications, Management Strategies, Prognostic Considerations.

Ozbek L, Abdel-Rahman S, Unlu S, Guldan M, Copur S, Burlacu A Medicina (Kaunas). 2024; 60(10).

PMID: 39459455 PMC: 11509396. DOI: 10.3390/medicina60101668.


The New Challenge of Obesity - Obesity-Associated Nephropathy.

Hao M, Lv Y, Liu S, Guo W Diabetes Metab Syndr Obes. 2024; 17:1957-1971.

PMID: 38737387 PMC: 11086398. DOI: 10.2147/DMSO.S433649.